New, detailed molecular roadmap boosted fight against endometrial cancer
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
Remdesivir prevented MERS coronavirus disease in monkeys
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
World experts and funders set priorities for COVID-19 research
On Feb. 12, 2020, leading health experts from around the world met at the World Health Organization’s (WHO)…
Vir Biotec identified two antibodies that bind to spike protein of SARS-CoV-2
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
Chembio Diagnostics received $1.5 million UNICEF order to combat Zika
On Feb. 12, 2020, Chembio Diagnostics announced a $1.5 million purchase order from UNICEF for multiplex Zika tests…
WHO and FIND formalized strategic collaboration to drive universal access to essential diagnostics
On Feb. 10, 2020, the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced…
UNMC researchers part of $32 million international project for drug development
On Feb. 7, 2020, two University of Nebraska Medical Center faculty members are among a group of researchers…
The Pan-cancer analysis of whole genomes was published in Nature
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
$675 million needed for new coronavirus preparedness and response global plan
On Feb. 5, 2020, to fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally,…
International collaboration generated most complete cancer genome map to date
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
BioMotiv and Bristol-Myers Squibb announced the Launch of Anteros Pharmaceuticals
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
CEPI and GSK announced collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
CDC released the 2020 recommended immunization schedules for children and adolescents, as well as for adults
On Feb. 3, 2020, the CDC released the 2020 recommended immunization schedules for children and adolescents, as well…
Mammoth Biosciences secured contract from NIH to scale high-throughput CRISPR SARS-CoV-2 diagnostic platform
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
Vaxart announced initiation of Coronavirus vaccine program
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
Taconic Biosciences Launched new immuno-oncology mouse model
On Jan 31, 2020, Taconic Biosciences announced that it had expanded its immuno-oncology portfolio with the launch of…
U.S. Department of Health and Human Services announced COVID-19 Public Health Emergency
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…
WHO declared coronavirus outbreak a global health emergency
On Jan. 30, 2020, The WHO announced that the outbreak of a deadly and fast-spreading strain of coronavirus…
The CDC confirmed person-to-person spread of new coronavirus in the U.S.
On Jan. 30, 2020, the Centers for Disease Control and Prevention (CDC) confirmed that the 2019 Novel Coronavirus…
Artificial Intelligence | Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics
New center to fund ‘most exciting’ biomedical discoveries
On Jan. 30, 2020, the University of Washington (UW) announced that a new center was being created with…
23andMe signed a strategic agreement with Almirall
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Therapeutics | Vaccine | Women's Health
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
WHO, China leaders discuss next steps in battle against coronavirus outbreak
On Jan. 28, 2020, the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, met President…
AbCellera mobilized response to the novel coronavirus outbreak as part of its DARPA P3 program
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
Alexion completed acquisition of Achillion for $930 million
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
Artificial Intelligence | Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics
Northeastern partners with entrepreneur David Roux to launch the Roux Institute at Northeastern University
On Jan. 27, 2020, the Jackson Laboratory announced it was one of the founding partners of the Roux…
GSK licensed tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development
On Jan. 27, 2020, GSK announced that it had licensed its M72/AS01E[3] tuberculosis disease (TB) vaccine candidate to…
The Cancer Prevention and Research Institute of Texas announced it had recruited its 200th CPRIT scholar
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
Bill & Melinda Gates Foundation donated $10 million to global response to 2019-nCOV
On Jan. 26, 2020, the Bill & Melinda Gates Foundation announced that it had immediately committed $10 million…